Display options
Cite
Cornejo Castro EM, Marshall V, Lack J, et al. Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples. Virus Evol. 2020;6(2):veaa047doi: 10.1093/ve/veaa047.
Cornejo Castro, E. M., Marshall, V., Lack, J., Lurain, K., Immonen, T., Labo, N., Fisher, N. C., Ramaswami, R., Polizzotto, M. N., Keele, B. F., Yarchoan, R., Uldrick, T. S., & Whitby, D. (2020). Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples. Virus evolution, 6(2), veaa047. https://doi.org/10.1093/ve/veaa047
Cornejo Castro, Elena M, et al. "Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples." Virus evolution vol. 6,2 (2020): veaa047. doi: https://doi.org/10.1093/ve/veaa047
Cornejo Castro EM, Marshall V, Lack J, Lurain K, Immonen T, Labo N, Fisher NC, Ramaswami R, Polizzotto MN, Keele BF, Yarchoan R, Uldrick TS, Whitby D. Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples. Virus Evol. 2020 Jun 30;6(2):veaa047. doi: 10.1093/ve/veaa047. eCollection 2020 Jul. PMID: 34211736; PMCID: PMC7474928.
Copy Download .nbib Format: NLM
Share it on

Virus Evol. 2020 Jun 30;6(2):veaa047. doi: 10.1093/ve/veaa047. eCollection 2020 Jul.

Dual infection and recombination of Kaposi sarcoma herpesvirus revealed by whole-genome sequence analysis of effusion samples.

Virus evolution

Elena M Cornejo Castro, Vickie Marshall, Justin Lack, Kathryn Lurain, Taina Immonen, Nazzarena Labo, Nicholas C Fisher, Ramya Ramaswami, Mark N Polizzotto, Brandon F Keele, Robert Yarchoan, Thomas S Uldrick, Denise Whitby

Affiliations

  1. Viral Oncology Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD 21702, USA.
  2. Advanced Biomedical Computing Center, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.
  3. HIV and AIDS Malignancy Branch, National Cancer Institute, 10 Center Dr, Bethesda, MD 20814, USA.
  4. Retroviral Evolution Section, AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD 21702, USA.

PMID: 34211736 PMCID: PMC7474928 DOI: 10.1093/ve/veaa047

Abstract

Kaposi sarcoma herpesvirus (KSHV) is the etiological agent of three malignancies, Kaposi sarcoma (KS), primary effusion lymphoma (PEL) and KSHV-associated multicentric Castelman disease. KSHV infected patients may also have an interleukin six-related KSHV-associated inflammatory cytokine syndrome. KSHV-associated diseases occur in only a minority of chronically KSHV-infected individuals and often in the setting of immunosuppression. Mechanisms by which KSHV genomic variations and systemic co-infections may affect the pathogenic pathways potentially leading to these diseases have not been well characterized

Published by Oxford University Press 2020. This work is written by US Government employees and is in the public domain in the US.

Keywords: KSHV; genetic diversity; recombination; virology; virus taxonomy

References

  1. J Infect Dis. 2018 Oct 20;218(11):1700-1710 - PubMed
  2. J Infect Dis. 2006 Feb 1;193(3):422-6 - PubMed
  3. Virology. 2012 Nov 10;433(1):220-5 - PubMed
  4. Cell. 2017 Sep 7;170(6):1164-1174.e6 - PubMed
  5. Blood. 1995 Aug 15;86(4):1276-80 - PubMed
  6. Genome Res. 2010 Sep;20(9):1297-303 - PubMed
  7. J Gen Virol. 2006 Jul;87(Pt 7):1781-1804 - PubMed
  8. J Virol. 2015 Dec;89(24):12299-308 - PubMed
  9. Nat Genet. 2019 Jul;51(7):1131-1136 - PubMed
  10. Semin Cancer Biol. 1999 Jun;9(3):165-74 - PubMed
  11. PLoS One. 2009;4(1):e4219 - PubMed
  12. J Med Virol. 2008 Dec;80(12):2153-60 - PubMed
  13. AIDS. 1999 Jul 9;13(10):1165-76 - PubMed
  14. J Clin Microbiol. 1999 Aug;37(8):2538-42 - PubMed
  15. Blood. 1996 Jul 15;88(2):645-56 - PubMed
  16. Mol Biol Evol. 2013 Apr;30(4):772-80 - PubMed
  17. J Virol. 2015 May;89(10):5222-37 - PubMed
  18. Bioinformatics. 2014 Aug 1;30(15):2114-20 - PubMed
  19. Chin J Cancer. 2015 Dec 16;34(12):563-72 - PubMed
  20. Mol Biol Evol. 2006 Feb;23(2):254-67 - PubMed
  21. Virology. 2001 Sep 30;288(2):358-68 - PubMed
  22. J Infect Dis. 2007 Mar 1;195(5):645-59 - PubMed
  23. Sci Rep. 2019 Jul 8;9(1):9829 - PubMed
  24. J Virol. 2014 Jan;88(2):1209-27 - PubMed
  25. Virus Evol. 2015 May 26;1(1):vev003 - PubMed
  26. Med Microbiol Immunol. 1999 Nov;188(2):83-9 - PubMed
  27. J Virol. 2006 Mar;80(6):2718-27 - PubMed
  28. J Natl Cancer Inst. 2007 Jun 20;99(12):962-72 - PubMed
  29. J Infect Dis. 2018 Aug 24;218(7):1061-1065 - PubMed
  30. J Clin Virol. 2002 Jan;23(3):119-48 - PubMed
  31. Blood. 2019 Apr 18;133(16):1753-1761 - PubMed
  32. J Infect Dis. 2012 Jun;205(11):1665-76 - PubMed
  33. J Virol. 1999 Jan;73(1):152-60 - PubMed
  34. J Infect Dis. 2010 Oct 1;202(7):1126-35 - PubMed
  35. Cancer Epidemiol. 2014 Apr;38(2):137-43 - PubMed
  36. J Virol. 2018 Mar 14;92(7): - PubMed
  37. J Clin Oncol. 2005 Jul 1;23(19):4372-80 - PubMed
  38. J Infect Dis. 2017 Oct 17;216(7):850-858 - PubMed
  39. Eur Respir J. 2013 Aug;42(2):470-9 - PubMed
  40. Curr Top Microbiol Immunol. 2007;312:1-42 - PubMed
  41. Curr Opin HIV AIDS. 2017 Jan;12(1):47-56 - PubMed
  42. N Engl J Med. 1995 May 4;332(18):1186-91 - PubMed
  43. J Virol. 2003 May;77(10):5578-88 - PubMed
  44. Bioinformatics. 2011 Nov 1;27(21):2987-93 - PubMed
  45. Clin Infect Dis. 2016 Mar 15;62(6):730-738 - PubMed
  46. J Infect Dis. 1999 Nov;180(5):1466-76 - PubMed
  47. J Gen Virol. 2010 Nov;91(Pt 11):2846-56 - PubMed
  48. Cancer. 2006 Nov 1;107(9):2282-90 - PubMed
  49. PLoS One. 2012;7(10):e46688 - PubMed
  50. Ann Oncol. 2009 Apr;20(4):775-9 - PubMed
  51. J Gen Virol. 2001 Oct;82(Pt 10):2393-2404 - PubMed
  52. J Virol. 1999 Aug;73(8):6953-63 - PubMed
  53. Br J Cancer. 2003 Aug 4;89(3):502-4 - PubMed
  54. J Virol. 2003 Jul;77(14):7978-90 - PubMed
  55. Curr Protoc Bioinformatics. 2014 Sep 08;47:11.12.1-34 - PubMed
  56. Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7 - PubMed
  57. Biol Blood Marrow Transplant. 2005 Jul;11(7):530-41 - PubMed
  58. Genetics. 2006 Apr;172(4):2665-81 - PubMed
  59. Cancer. 1977 Jun;39(6):2348-54 - PubMed
  60. J Virol. 2003 Jan;77(1):592-9 - PubMed
  61. Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33 - PubMed
  62. J Infect Dis. 2000 May;181(5):1562-8 - PubMed
  63. Int J Cancer. 2019 May 1;144(9):2206-2214 - PubMed
  64. Bioinformatics. 2009 Aug 15;25(16):2078-9 - PubMed
  65. J Virol. 2015 Jul;89(14):7214-23 - PubMed
  66. N Engl J Med. 2008 Jan 31;358(5):535-6; author reply 536 - PubMed
  67. PLoS Pathog. 2014 Jan;10(1):e1003847 - PubMed
  68. J Virol. 1999 May;73(5):4156-70 - PubMed
  69. JAMA. 2011 Nov 2;306(17):1891-901 - PubMed
  70. Rev Med Virol. 2007 Jan-Feb;17(1):45-57 - PubMed
  71. J Virol. 1999 Aug;73(8):6646-60 - PubMed
  72. Bioinformatics. 2010 Mar 15;26(6):841-2 - PubMed
  73. Br J Cancer. 2003 Jan 13;88(1):1-3 - PubMed
  74. Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W5-9 - PubMed
  75. Blood. 2011 Jun 30;117(26):6977-86 - PubMed
  76. Virus Res. 2018 May 2;250:75-80 - PubMed
  77. J Mol Biol. 1990 Oct 5;215(3):403-10 - PubMed
  78. J Natl Cancer Inst. 2000 May 3;92(9):729-36 - PubMed
  79. Science. 1994 Dec 16;266(5192):1865-9 - PubMed

Publication Types